![Gary Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Lee
Hoofd Techniek/Wetenschap/O&O bij
LYELL IMMUNOPHARMA, INC.
Vermogen: 232 270 $ op 31-08-2026
Profiel
Gary Lee is currently Chief Scientific Officer at Lyell Immunopharma, Inc. since 2022.
Formerly, Dr. Lee was Vice President-Cell Therapy at Sangamo Therapeutics, Inc. from 2005 to 2018 and Chief Scientific Officer at Senti Sub I, Inc. from 2018 to 2022.
Education includes undergraduate studies at California Institute of Technology and a doctorate from the University of California, Berkeley.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-08-2026 | 16.220 ( 0,07% ) | 232 270 $ | 31-08-2026 |
Actieve functies van Gary Lee
| Bedrijven | Functie | Begin |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 31-01-2022 |
Eerdere bekende functies van Gary Lee
| Bedrijven | Functie | Einde |
|---|---|---|
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01-10-2018 |
Opleiding van Gary Lee
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
63
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
